Topiramate Good Manufacturer supply High Quality 97240-79-4
- Molecular Formula:C12H21NO8S
- Molecular Weight:339.367
- Appearance/Colour:white to off-white crystalline powder
- Vapor Pressure:6.76E-08mmHg at 25°C
- Melting Point:125 °C
- Refractive Index:1.497
- Boiling Point:438.7 °C at 760 mmHg
- PKA:9.22±0.70(Predicted)
- Flash Point:219.1 °C
- PSA：123.92000
- Density:1.336 g/cm3
- LogP:1.38570
Topiramate (97240-79-4) Usage
Topiramate, a novel sulfamate-substituted D-fructose derivative, was launched in the United Kingdom as an adjunct therapy for use in partial seizures with or without secondary generalized seizures in adult patients inadequately controlled on conventional antiepileptics. Topiramate is structurally distinct from other available antiepileptics and functions through a unique combination of several mechanisms. It appears to act by blocking voltage-sensitive sodium channels to raise the action potential threshold and block the spread of seizure, enhancing GABA activity at postsynaptic GABA receptors and reducing glutamate activity at postsynaptic AMPAtype receptors, and is also a carbonic anhydrase inhibitor. Topiramate is orally active with rapid absorption, high bioavailability, and long duration of action. Excellent efficacy has been reported as an add-on therapy in epilepsy and it is also being evaluated as a monotherapy.
How to get the best price on Topiramate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Topiramate . You can buy high quality, low price Topiramate 97240-79-4 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
